![Andrew Almond](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Almond
Director/Board Member at Imperagen Ltd.
Profile
Andrew Almond is the founder of C4X Discovery Ltd.
(founded in 2008) and C4X Discovery Holdings Plc (founded in 2008), where he held the title of Director & Chief Technology Officer (2008-2013) and Chief Technical Officer (inactive).
He is currently a Director at Imperagen Ltd.
(since 2021).
Dr. Almond obtained a doctorate degree from The University of Manchester and an undergraduate degree from The University of Edinburgh.
Andrew Almond active positions
Companies | Position | Start |
---|---|---|
Imperagen Ltd.
![]() Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Director/Board Member | 22/11/2021 |
Former positions of Andrew Almond
Companies | Position | End |
---|---|---|
C4X DISCOVERY HOLDINGS PLC | Founder | - |
C4X Discovery Ltd.
![]() C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Founder | - |
Training of Andrew Almond
The University of Manchester | Doctorate Degree |
The University of Edinburgh | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
C4X DISCOVERY HOLDINGS PLC | Health Technology |
Private companies | 2 |
---|---|
C4X Discovery Ltd.
![]() C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Imperagen Ltd.
![]() Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Commercial Services |
- Stock Market
- Insiders
- Andrew Almond